TRANSCODE THERAPEUTICS INC - COM (RNAZ)

CUSIP: 89357L105

Q4 2021 13F Holders as of 31 Dec 2021

Share change
-84,213
SEC-reported price per share
$2.54
Number of holders
14
Value change
-$322,820
Number of buys
7
Number of sells
6

Security key

89357L105

Report period

Q4 2021

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of RNAZ - TRANSCODE THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Anna Moore
Disclosed value leader
AIGH Capital Management LLC
Comparable rows
0/15
Latest evidence
30 Sep 2021
3/4/5 13F Highest disclosed value: $3,798,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AIGH Capital Management LLC has the largest disclosed position value at $3.8M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AIGH Capital Management LLC's linked filing trail.
Disclosed position value Top 5
Anna Moore $791.9K
AIGH Capital Management LLC $3.8M
Kepos Capital LP $897K
Worth Venture Partners, LLC $884K
VANGUARD GROUP INC $598K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Anna Moore
3/4/5
10%+ Owner
—
denominator unverified
$791,920
1,552,785 shares
— 08 Jul 2021
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$3,798,000
1,270,500 shares
— 30 Sep 2021
Kepos Capital LP
13F
Company
13F
—
denominator unverified
$897,000
300,000 shares
— 30 Sep 2021
Worth Venture Partners, LLC
13F
Company
13F
—
denominator unverified
$884,000
295,518 shares
— 30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$598,000
200,117 shares
— 30 Sep 2021
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$271,000
90,774 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
2,354,078
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
16
Q4 2021 holders
14
Holder diff
-2
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .